Yarrow Bioscience's current assets is $30K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Yarrow Bioscience (YARW) currently reports a current assets of $30K as of June 2026. That compares with $44M in the prior-year period — down 99.9% year over year. Use the charts on this page to explore Yarrow Bioscience's current assets history and peer comparisons.
Yarrow Bioscience's current assets decreased from $44M to $30K — a 99.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Yarrow Bioscience reported $30K in current assets as of June 2026. That compares with $44M in the prior-year period — down 99.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current assets of $30K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Yarrow Bioscience, and consider following YARW for alerts when major investors trade the stock.
Yarrow Bioscience is classified in the Healthcare sector. On current assets, it currently shows $30K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing YARW with unrelated industries.